Stock Scorecard
Stock Summary for BridgeBio Pharma Inc (BBIO) - $63.88 as of 6/3/2026 3:41:19 PM EST
Total Score
3 out of 30
Safety Score
44 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for BBIO
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for BBIO
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for BBIO
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for BBIO
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for BBIO (44 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for BBIO
Financial Details for BBIO
Company Overview |
|
|---|---|
| Ticker | BBIO |
| Company Name | BridgeBio Pharma Inc |
| Country | USA |
| Description | BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases. The company is headquartered in Palo Alto, California. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 3/31/2026 |
| Next Earnings Date | 8/4/2026 |
Stock Price History |
|
| Last Day Price | 63.88 |
| Price 4 Years Ago | 7.62 |
| Last Day Price Updated | 6/3/2026 3:41:19 PM EST |
| Last Day Volume | 4,697,517 |
| Average Daily Volume | 2,955,481 |
| 52-Week High | 84.94 |
| 52-Week Low | 37.57 |
| Last Price to 52 Week Low | 70.03% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 80.56 |
| Sector PE | 58.19 |
| 5-Year Average PE | -26.04 |
| Free Cash Flow Ratio | 14.23 |
| Industry Free Cash Flow Ratio | 28.83 |
| Sector Free Cash Flow Ratio | 25.14 |
| Current Ratio Most Recent Quarter | 1.44 |
| Total Cash Per Share | 4.49 |
| Book Value Per Share Most Recent Quarter | -10.71 |
| Price to Book Ratio | 123.68 |
| Industry Price to Book Ratio | 10.66 |
| Sector Price to Book Ratio | 8.28 |
| Price to Sales Ratio Twelve Trailing Months | 22.07 |
| Industry Price to Sales Ratio Twelve Trailing Months | 9.91 |
| Sector Price to Sales Ratio Twelve Trailing Months | 9.46 |
| Analyst Buy Ratings | 16 |
| Analyst Strong Buy Ratings | 6 |
Share Statistics |
|
| Total Shares Outstanding | 195,861,000 |
| Market Capitalization | 12,511,600,680 |
| Institutional Ownership | 102.54% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -36.12% |
| Reported EPS 12 Trailing Months | -3.74 |
| Reported EPS Past Year | -0.84 |
| Reported EPS Prior Year | -3.60 |
| Net Income Twelve Trailing Months | -725,927,000 |
| Net Income Past Year | -729,306,000 |
| Net Income Prior Year | -535,762,000 |
| Quarterly Revenue Growth YOY | 66.80% |
| 5-Year Revenue Growth | 127.44% |
| Operating Margin Twelve Trailing Months | -54.50% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 879,891,000 |
| Total Cash Past Year | 570,119,000 |
| Total Cash Prior Year | 681,101,000 |
| Net Cash Position Most Recent Quarter | -1,046,187,000 |
| Net Cash Position Past Year | -1,282,351,000 |
| Long Term Debt Past Year | 1,852,470,000 |
| Long Term Debt Prior Year | 1,721,382,000 |
| Total Debt Most Recent Quarter | 1,926,078,000 |
| Equity to Debt Ratio Past Year | 0.00 |
| Equity to Debt Ratio Most Recent Quarter | 0.00 |
| Total Stockholder Equity Past Year | -2,076,581,000 |
| Total Stockholder Equity Prior Year | -1,467,904,000 |
| Total Stockholder Equity Most Recent Quarter | -2,268,875,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -454,120,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -2.32 |
| Free Cash Flow Past Year | -447,007,000 |
| Free Cash Flow Prior Year | -521,659,000 |
Options |
|
| Put/Call Ratio | 0.19 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 64.95 |
| 20-Day Bollinger Middle Band | 73.11 |
| 20-Day Bollinger Upper Band | 81.27 |
| Beta | 1.02 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 6/2/2026 6:16:55 PM EST |